Vaniprevir Withdrawn Phase 2 Trials for Chronic Genotype 1 Hepatitis C Virus Infection Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Withdrawn | Treatment | 2 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT00895882 | Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN) |